ResearcherInsermActive in the last 2 years
Renato Micelli Lupinacci
Matched on ORCID iD 0000-0003-2527-7949; OpenAlex author ID A5034714383. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 3, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 19
2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: 2 papers · 2022: none · 2023: 2 papers · 2024: 1 paper · 2025: none · 2026: 1 paper
Papers 8
- International survey on neoadjuvant treatments in anatomically resectable pancreatic adenocarcinoma (INSPIRA): a real-life snapshot. Co-author DOI 10.1016/j.suronc.2026.102580↗
- Should liver metastases of pancreatic adenocarcinoma be resected? First author DOI 10.1016/j.jviscsurg.2023.12.006↗
- FROM LEFT TO RIGHT. PARA-AORTIC LYMPH NODES SAMPLING DURING PANCREATODUODENECTOMY FOR PANCREATIC CANCER. Last author DOI 10.1590/0102-672020230054e1772↗
- Pancreatic cancer orthotopic graft in a murine model. Co-author DOI 10.1590/acb382823↗
- Acute Pancreatitis as the Initial Presentation of Pancreatic Adenocarcinoma does not Impact Short- and Long-term Outcomes of Curative Intent Surgery: A Study o… Co-author DOI 10.1007/s00268-021-06205-1↗
- Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review of Clinical-Pathological Features, Outcom… First author DOI 10.3390/ijms22136756↗
- Pancreatic ductal adenocarcinoma harboring microsatellite instability / DNA mismatch repair deficiency. Towards personalized medicine. Co-author DOI 10.1016/j.suronc.2018.11.019↗
- Number of examined lymph nodes and nodal status assessment in pancreaticoduodenectomy for pancreatic adenocarcinoma. First author DOI 10.1016/j.ejso.2013.07.089↗
Closest collaborators
The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jean‐Baptiste Bachet · 4 shared papers, 2013–2024 · strength 0.57
- Paper Should liver metastases of pancreatic adenocarcinoma be resected? DOI 10.1016/j.jviscsurg.2023.12.006↗
- Paper Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review o… DOI 10.3390/ijms22136756↗
- Paper Pancreatic ductal adenocarcinoma harboring microsatellite instability / DNA mismatch repair deficiency. Towards persona… DOI 10.1016/j.suronc.2018.11.019↗
- Milena Muzzolini · 2 shared papers, 2023–2024 · strength 0.45
- Alain Sauvanet Sauvanet · 2 shared papers, 2021–2024 · strength 0.39
- Magali Svrcek · 3 shared papers, 2013–2021 · strength 0.32
- Paper Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review o… DOI 10.3390/ijms22136756↗
- Paper Pancreatic ductal adenocarcinoma harboring microsatellite instability / DNA mismatch repair deficiency. Towards persona… DOI 10.1016/j.suronc.2018.11.019↗
- Paper Number of examined lymph nodes and nodal status assessment in pancreaticoduodenectomy for pancreatic adenocarcinoma. DOI 10.1016/j.ejso.2013.07.089↗
- Gabrielle Stevenin · 1 shared paper, 2023 · strength 0.31
- Sébastien Gaujoux · 1 shared paper, 2024 · strength 0.26
- Annemilaï Tijeras‐Raballand · 1 shared paper, 2023 · strength 0.19
- Cindy Neuzillet · 1 shared paper, 2023 · strength 0.19
- Corinne Bousquet · 1 shared paper, 2023 · strength 0.19
- Victoire Cardot‐Ruffino · 1 shared paper, 2023 · strength 0.19
- Christine Jean · 1 shared paper, 2023 · strength 0.19
- François Paye · 2 shared papers, 2013–2021 · strength 0.16
- Paper Acute Pancreatitis as the Initial Presentation of Pancreatic Adenocarcinoma does not Impact Short- and Long-term Outcom… DOI 10.1007/s00268-021-06205-1↗
- Paper Number of examined lymph nodes and nodal status assessment in pancreaticoduodenectomy for pancreatic adenocarcinoma. DOI 10.1016/j.ejso.2013.07.089↗
- Léo Mas · 1 shared paper, 2021 · strength 0.16
- Jerome F. Cros · 1 shared paper, 2021 · strength 0.16
- Jean‐Robert Delpéro · 1 shared paper, 2021 · strength 0.13
- Mustapha Adham · 1 shared paper, 2021 · strength 0.13
- Philippe Bachellier · 1 shared paper, 2021 · strength 0.13
- Thierry André · 1 shared paper, 2019 · strength 0.12
- Helene Vuarnesson · 1 shared paper, 2013 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.